Maze Therapeutics, Inc. Common Stock (NASDAQ: MAZE) last traded at $26.66, down 3.75% on the session. The quote above updates while this page is open; the figures below are drawn from Maze Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Maze Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker MAZE. Its market capitalisation is $1.48 billion.
Valuation measures for Maze Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.48B |
|---|---|
| Enterprise value | $1.36B |
| Price / book | 3.27 |
| Beta | 0.72 |
Trailing-twelve-month figures tagged in Maze Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$133.59M |
| EPS (TTM) | -$2.34 |
|---|
| Return on equity | -29.48% |
|---|
| Cash | $202.64M |
|---|
Range and volume for MAZE over the past 52 weeks.
| 52-week high | $53.65 |
|---|---|
| 52-week low | $21.95 |
| Volume | 615.1K |
| Average volume | 578.5K |
| Previous close | $27.70 |
Invest a chosen dollar amount in Maze Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell MAZE.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.